Syros Pharmaceuticals

SYRS · OTC

$0.0004+$0.00 (+0.00%)TodayMarket closed · Oct 20, 3:35 PM ET

Prev close $0.0004

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 68 full-time employees. The company went IPO on 2016-06-30. The firm is actively engaged in the voluntary delisting process. The firm was previously engaged in developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Employees: 68
Headquarters: Cambridge, Massachusetts
Listed: Jun 30, 2016
Sector: Health Care
Industry: Biotechnology
Website: syros.com

Leadership

Syros Pharmaceuticals executives
Name	Title	Since	Age
Kristin Stephens	—	—	51
Gerald Quirk	—	2016	56
Hannah Deresiewicz	—	2017	—

Similar companies

Companies in the same industry as Syros Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.